Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Frederik N Engsig, Jan Gerstoft, Gitte Kronborg, Carsten Schade Larsen, Gitte Pedersen, Anne M Audelin, Louise B Jørgensen, Niels Obel

4 Citationer (Scopus)

Abstract

Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.
OriginalsprogEngelsk
TidsskriftClinical Epidemiology
Vol/bind2
Sider (fra-til)145-51
Antal sider7
ISSN1179-1349
StatusUdgivet - 1 jan. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen'. Sammen danner de et unikt fingeraftryk.

Citationsformater